AIM IMMUNOTECH INC. Interest Payable, Current
AIM IMMUNOTECH INC. (AIM) had Interest Payable, Current of $24.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-07
- 2026-06-30: Interest Payable, Current $24.00K.
- 2026-03-31: Interest Payable, Current $34.00K.
- 2025-12-31: Interest Payable, Current $64.00K.
- 2025-09-30: Interest Payable, Current $16.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $24.00K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $34.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $64.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-17 |
| 2025-06-30 | $106.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $44.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $11.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $51.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $118.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |